Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection

被引：0
|
作者：
Michej, W. [1 ]
机构：
[1] Canc Ctr Inst Warsaw, Dept Pathol, Warsaw, Poland
来源：
VIRCHOWS ARCHIV | 2012年 / 461卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [21] Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp
    Kasper, Bernd
    Lossignol, Dominique
    Gil, Thierry
    Flamen, Patrick
    De Saint Aubain, Nicolas
    Awada, Ahmad
    ANTI-CANCER DRUGS, 2006, 17 (10) : 1223 - 1225
  • [22] Response to imatinib mesylate (IM) in fibrosarcoma (FS) arising in dermatofibrosarcoma protuberans (DFSP)
    Gronchi, A.
    Stacchiotti, S.
    Pedeutour, F.
    Collini, P.
    Tamborini, E.
    Morosi, C.
    Crippa, F.
    Pastorino, U.
    Pilotti, S.
    Casali, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Dermatofibrosarcoma protuberans in a patient with acquired immune deficiency syndrome responding to imatinib mesylate
    Horner, K.
    Adams, D.
    Ioffreda, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 : 16 - 17
  • [24] Imatinib mesylate treatment for a Chinese patient with metastatic and recurrent dermatofibrosarcoma protuberans: is sustained partial remission possible?
    Wang, Chunmeng
    Luo, Zhiguo
    Zheng, Biqing
    Chen, Yong
    Cao, Xi
    Wang, Jian
    Zhang, Ruming
    Shi, Yingqiang
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2012, 21 (06) : 585 - 587
  • [25] SURGICAL-TREATMENT OF DERMATOFIBROSARCOMA PROTUBERANS
    ROSES, DF
    VALENSI, Q
    LATRENTA, G
    HARRIS, MN
    SURGERY GYNECOLOGY & OBSTETRICS, 1986, 162 (05): : 449 - 452
  • [26] Systemic therapy in advanced dermatofibrosarcoma protuberans: Imatinib and beyond.
    Gupta, Anshul
    Rastogi, Sameer
    Kumar, Santosh C.
    Barwad, Adarsh
    Dhamija, Ekta
    Panday, Rambha
    Deo, S. V. S.
    Shishak, Sorun
    Aggarwal, Aditi
    Dutta, Rimlee
    Manasa, Parisa
    Kumar, Pankaj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] A favorable outcome of advanced dermatofibrosarcoma protuberans under treatment with sunitinib after imatinib failure
    Xiao, Wei
    Que, Yi
    Peng, Ruiqing
    Ding, Ya
    Zhao, Jingjing
    Wen, Xizhi
    Weng, Desheng
    Zhang, Xiaoshi
    Guan, Yuanxiang
    Zhang, Xing
    ONCOTARGETS AND THERAPY, 2018, 11 : 2439 - 2443
  • [28] Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib
    Dennis A Wicherts
    Frits van Coevorden
    Houke M Klomp
    Martine A van Huizum
    J Martijn Kerst
    Rick LM Haas
    Hester H van Boven
    JA van der Hage
    World Journal of Surgical Oncology, 11
  • [29] Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib
    Wicherts, Dennis A.
    van Coevorden, Frits
    Klomp, Houke M.
    van Huizum, Martine A.
    Kerst, J. Martijn
    Haas, Rick L. M.
    van Boven, Hester H.
    van der Hage, J. A.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [30] Imatinib mesylate: An attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans
    Price, VE
    Fletcher, JA
    Zielenska, M
    Cole, W
    Viero, S
    Manson, DE
    Stuart, M
    Pappo, AS
    PEDIATRIC BLOOD & CANCER, 2005, 44 (05) : 511 - 515
12345